Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
Authors:
Open Access
- 25 April 2025
- journal article
- case report
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 4 (3) , 100490
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Successful discontinuation of corticosteroids through remission induction therapy with benralizumab for chronic eosinophilic pneumoniaRespirology Case Reports, 2024
- Case Report: Eosinophilic Bronchiolitis With Eosinophil ETosis in Mucus Plugs Successfully Treated With BenralizumabFrontiers in Pharmacology, 2022
- Clinical characteristics of patients with chronic eosinophilic pneumonia in a Chinese tertiary‐care hospital: A 6‐year retrospective studyThe Clinical Respiratory Journal, 2021
- Possible Mechanisms of Eosinophil Accumulation in Eosinophilic PneumoniaBiomolecules, 2020
- The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitisAllergology International, 2020
- Autopsy and Imaging Studies of Mucus in Asthma. Lessons Learned about Disease Mechanisms and the Role of Mucus in Airflow ObstructionAnnals of the American Thoracic Society, 2018
- Persistent impairment on spirometry in chronic eosinophilic pneumoniaAnnals of Allergy, Asthma & Immunology, 2017
- Measurement of FEF25–75%and FEF75%does not contribute to clinical decision makingEuropean Respiratory Journal, 2013
- Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?European Respiratory Journal, 2003